Updated: Amgen sued in federal court for allegedly hiding $10.7B IRS bill from investors
Almost a year after Amgen told investors that the IRS wanted billions of dollars in back taxes, a Detroit pension fund is taking on Amgen in federal court — proposing a class action jury trial against the pharma giant.
In the 42-page complaint (case 1:23-cv-02138-ER) filed in federal district court in Manhattan on Monday, Roofers Local No. 149 Pension Fund sued Amgen, CEO Robert Bradway and CFO Peter Griffith, accusing the company of hiding its tax information from investors and delaying reporting of the claimed back taxes — effectively making “false and misleading statements,” according to the filing.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters